Monitoring of minimal residual disease in NPM1 mutated acute myeloid leukemia (AML) – a single center experience in 27 patients.
| Authors | |
|---|---|
| Year of publication | 2009 |
| Type | Article in Periodical |
| Magazine / Source | Blood |
| MU Faculty or unit | |
| Citation | |
| Related projects: |